Clinical Trials
42 trialsProspective Evaluation of Biliary Tissue Sampling With ERCP
Mayo Clinic
TraveraRTGx
Travera Inc
Comparing the TDTP-RECIST With RECIST 1.1 and Other Volumetric Evaluation Methods for Assessing the Therapeutic Efficacy of Irregular Malignant Tumors
Shanghai Zhongshan Hospital
A Study on Intratumoral Fibrosis and α-SMA Expression in Intrahepatic Cholangiocarcinoma
First Affiliated Hospital, Sun Yat-Sen University
LyMIC
City of Hope Medical Center
EXOMIC
City of Hope Medical Center
LUMIC
City of Hope Medical Center
Diagnostic Efficacy of EUS-FNA/B Versus ERCP With or Without POCS-TB in Patients With Suspected Hilar Cholangiocarcinoma
Qilu Hospital of Shandong University
EchoTip AcuCore Post-Market Clinical Study
Cook Group Incorporated
Biomarker Discovery in Patients With Advanced Biliary Tract Cancer
CHA University
POELH-II
Erasmus Medical Center
Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs
Alaunos Therapeutics
Laparotomy, Laparoscopy, da Vinci System
National Chung Hsing University
EyeMAX-CREGG
Clinique Paris-Bercy
Clinico-demographic Profile of the Patient With Pancreaticobiliary Malignancy Undergoing ERCP in a Tertiary Care Center of Nepal
Kathmandu University School of Medical Sciences
ROOT
Taproot Health
Long-term Morbidity After Surgery for Perihilar Cholangiocarcinoma
University of Liverpool
A Machine-learning Model to Predict Lymph Node Metastasis of Intrahepatic Cholangiocarcinoma
West China Hospital
Endoscopy and Primary Sclerosing Cholangitis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
MIRABILE
Imperial College London
Recurrence After Whipple's (RAW) Study
University Hospital Plymouth NHS Trust
Cholangioscopy in Primary Sclerosing Cholangitis (PSC)
Boston Scientific Corporation
HAIC Plus Targeted Therapy and/or PD-1 Inhibitors for Unresectable Intrahepatic Cholangiocarcinoma
Sun Yat-sen University
PSC
Karolinska University Hospital
RESiN
Vanderbilt-Ingram Cancer Center
ESCULAP
University Hospital Erlangen
Advanced Endoscopy During COVID-19
Al-Azhar University
Clinical and Histopathologic Characteristics of BAP1 Mutations
Memorial Sloan Kettering Cancer Center
METSLIVER
Assistance Publique - Hôpitaux de Paris
Surgery for Recurrent Intrahepatic Cholangiocarcinoma
Chang Gung Memorial Hospital
Diagnosis of Bile Duct Strictures
Washington University School of Medicine
Changes in Liver Function After Stereotactic Body Radiation Therapy Measured by PET/CT
University of Aarhus
RALPPS in Patients With Hilar and Intrahepatic Cholangiocarcinoma
Moscow Clinical Scientific Center
Analysis of Oncogenes in Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Tumor Tissue Samples
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Combined HCC-MFCCC
University of Milan
ONCOBIL
CHU de Reims
Factors Influencing the 3-Year Recurrence of Liver Carcinoma After Surgery
Chulabhorn Hospital
Quantitative Real-time Ultrasound Elastography for Characterisation of Liver Tumors
University Hospital Dubrava
FOCUS
Mauna Kea Technologies
Role of Bile Duct Resection in Major Hepatectomy Due to Intrahepatic Cholangiocarcinoma
Kansai Hepatobiliary Oncology Group
Prospective Liver Study
Emory University
Cytological Evaluation of Biliary Epithelium After Endoscopic Sphincterotomy
University of Athens